Global Tissue Engineering and Regeneration Market Set to Surge at 12.8% CAGR Through 2030

“Fueled by the growing burden of chronic diseases, increased research activity, and strong venture capital support, the market is rapidly evolving with innovations in biomaterials, scaffolds, and regenerative therapies, offering strategic opportunities for companies worldwide.”

Boston, Aug. 19, 2025 (GLOBE NEWSWIRE) -- According to the latest study from BCC Research, the “Tissue Engineering and Regeneration: Technologies and Global Markets” is estimated to increase from $5.4 billion in 2025 to $9.8 billion by the end of 2030, at a compound annual growth rate (CAGR) of 12.8% from 2025 through 2030.

The report provides a detailed review of the global tissue engineering and regeneration market, analyzing trends across product types (scaffolds and tissue grafts), materials (biologically derived and synthetic), and applications such as orthopedic, dermatology, dental, cardiovascular, and others. It covers the key geographical regions of North America, Europe, Asia-Pacific, the Middle East and Africa, and South America.

The study highlights major market drivers, challenges, ESG developments, and emerging technologies. It concludes with an analysis of the competitive landscape, including company rankings, financials, product portfolios, and recent developments of leading players.

The factors driving the market’s growth include:

Rising Demand for Regenerative Medicine: The increasing need for regenerative medicine is driven by an aging population, rising cases of chronic diseases, and a global shortage of donor organs. Innovations like stem cell therapy and tissue regeneration offer promising alternatives, fueling demand for advanced tissue engineering solutions.

Growing Research and Approvals in Tissue Engineering : Research in tissue engineering is expanding rapidly, with breakthroughs in biomaterials, 3D bioprinting, and scaffold technologies. Regulatory bodies are approving more products, and collaborations between academia and industry are accelerating the translation of lab discoveries into clinical applications.

Increasing Venture Capital Funding: Venture capital investment is boosting the growth of tissue engineering by supporting startups and biotech firms. This funding enables research, product development, and commercialization, while also leading to mergers and acquisitions that strengthen the market landscape.

Request a sample copy of the global market for tissue engineering and regeneration report.

Report Synopsis

Interesting facts:

• The tissue engineering and regeneration market is fragmented, with a mix of large corporations, SMEs, and startups. This diversity drives competition and fosters cutting-edge innovation across the industry.

• Many tissue engineering and regeneration companies have emerged as spin-offs from academic and research institutions. This trend highlights the successful translation of scientific research into commercially viable solutions, bridging the gap between lab discoveries and real-world clinical applications.

• Artificial intelligence augments biomaterial discovery, improves scaffold architecture, and allows for the predictive modeling of tissue behavior. This leads to faster R&D cycles and significant cost reductions across tissue engineering and clinical translation efforts.

Emerging startups:

• 4D Medicine: 4D Medicine, a UK spin-out from Birmingham and Warwick universities, raised $4.4 million in Series A funding to advance 4Degra, its resorbable biomaterial for 3D-printed implants and soft tissue scaffolds, toward FDA clearance.

• Alicorn Medical: Alicorn Medical, founded in 2017, is an India-based innovator in tissue-engineered wound care. Through academic collaborations, it developed CholeDerm, India’s first tissue-engineered wound product, focused on affordability and accessibility.

The report addresses the following questions:

1. What are the projected size and growth rate of the tissue engineering and regeneration market?

• The global tissue engineering and regeneration market was $4.8 billion in 2024. The market is expected to grow at a compound annual growth rate (CAGR) of 12.8%, reaching about $9.8 billion by the end of 2030.

2. Which factors are driving the growth of the market?

• The tissue engineering and regeneration market is driven by rising demand for regenerative medicine, growing research and regulatory approvals, and increasing venture capital funding.

3. Which market segments are covered in the report?

• The tissue engineering and regeneration market is segmented based on product, material, application, and region.

4. Which product type will be dominant through 2029?

• Scaffolds will dominate the market through 2030.

5. Which region has the highest tissue engineering and regeneration market share?

• North America holds the highest share of the market.

Market leaders include:

• Abbvie Inc.
• Alicorn Medical Pvt. Ltd.
• Baxter International
• B. Braun SE
• Becton Dickinson
• Biotissue Integra Lifesciences
• Johnson & Johnson
• Medtronic
• Mimedx Group Inc .
• Organogenesis Inc.
• Smith+Nephew
• Stryker
• Tecnoss
• Zimmer Biomet

Purchase a copy of the report direct from BCC Research.

For further information on any of these reports or to make a purchase, contact info@bccresearch.com.    

About BCC Research

BCC Research market research reports provide objective, unbiased measurement and assessment of market opportunities. Our experienced industry analysts' goal is to help you make informed business decisions free of noise and hype.

For media inquiries, email press@bccresearch.com or visit our media page for access to our market research library.

Any data and analysis extracted from this press release must be accompanied by a statement identifying BCC Research LLC as the source and publisher.

CONTACT: BCC Research

Corporate HQ: 50 Milk St., Ste. 16, Boston, MA 02109, USA
Email: info@bccresearch.com
Phone: +1 781-489-7301